Open-Angle Glaucoma Market Report 2032 | Aerie Pharmaceuticals, Alcon Research, Allergan, Bausch and Lomb, Chong Kun Dang Pharmaceutical, D.Western Therapeutics Institute (DWTI)/Kowa LTD., Envisia Therapeutics, Laboratorios Sophia S.A de C.V., Merck Sharp

DelveInsight's "Open-Angle Glaucoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Open-Angle Glaucoma, historical and forecasted epidemiology as well as the Open-Angle Glaucoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Open-Angle Glaucoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Open-Angle Glaucoma market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Open-Angle Glaucoma treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Open-Angle Glaucoma market.

Request for a Free Sample Report @ https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma: An Overview

Open-angle glaucoma is a type of glaucoma, which is a group of eye conditions that damage the optic nerve, the part of the eye that carries images to the brain. When this nerve is damaged or destroyed, vision loss can occur. Open-angle glaucoma is the most common form of glaucoma and is characterized by a wide, open angle where the iris meets the cornea.

Causes

The primary cause of open-angle glaucoma is an increase in intraocular pressure (IOP), which is the pressure inside the eye. This pressure can damage the optic nerve, particularly at the point where it leaves the eye to carry visual information to the brain. The increased pressure is often due to the eye's drainage system for aqueous humor (the clear fluid inside the eye) not working properly.

Risk factors for open-angle glaucoma include:

- Age (over 40)
- Family history of glaucoma
- African, Hispanic, or Asian descent
- High myopia (severe nearsightedness)
- Thin corneas (which can make the eye pressure test less accurate)
- Certain medical conditions, such as diabetes, high blood pressure, and sickle cell anemia

Signs and Symptoms

Open-angle glaucoma is often referred to as the "silent thief of sight" because it can develop slowly, usually over years, and often has no symptoms until significant vision loss has occurred. However, some possible signs and symptoms include:

- Gradual loss of peripheral vision (side vision)
- Tunnel vision in the advanced stages
- Seeing halos around lights
- Blurred vision
- Reduced ability to see at night
- Eye pain or discomfort (less common)

Diagnosis

Diagnosing open-angle glaucoma typically involves a comprehensive eye exam that may include:

- Tonometry: Measures the pressure inside the eye.
- Gonioscopy: Examines the drainage angle of the eye using a special lens and light.
- Ophthalmoscopy: Examines the optic nerve for signs of damage.
- Visual field test: Assesses peripheral vision.
- Optical coherence tomography (OCT): Provides detailed images of the optic nerve and retinal nerve fiber layer.

Treatment Options

The primary goal of treating open-angle glaucoma is to lower intraocular pressure to prevent further damage to the optic nerve. Treatment options for open-angle glaucoma include:

- Eye drops: Medications that reduce eye pressure by either decreasing the amount of fluid produced by the eye or improving the outflow of fluid from the eye.
- Oral medications: In some cases, pills may be prescribed to help lower eye pressure.
- Laser treatment: Laser trabeculoplasty can help improve fluid drainage from the eye.
- Surgery: Trabeculectomy or minimally invasive glaucoma surgeries (MIGS) can create a new pathway for fluid to leave the eye or implant a drainage device.

Regular follow-up exams are essential to monitor the progression of the disease and the effectiveness of the treatment. Early detection and treatment are crucial in managing open-angle glaucoma and preserving vision.

Learn more about Open-Angle Glaucoma, treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Market

The Open-Angle Glaucoma market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Open-Angle Glaucoma market trends by analyzing the impact of current Open-Angle Glaucoma therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Open-Angle Glaucoma market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Open-Angle Glaucoma market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Open-Angle Glaucoma market in 7MM is expected to witness a major change in the study period 2019-2032.

Request a sample and discover more about the report offerings at:
https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Epidemiology

The Open-Angle Glaucoma epidemiology section provides insights into the historical and current Open-Angle Glaucoma patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Open-Angle Glaucoma market report also provides the diagnosed patient pool, trends, and assumptions.

Explore more about Open-Angle Glaucoma Epidemiology at: https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Drugs Uptake

This section focuses on the uptake rate of the potential Open-Angle Glaucoma drugs recently launched in the Open-Angle Glaucoma market or expected to be launched in 2019-2032. The analysis covers the Open-Angle Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug.

Open-Angle Glaucoma Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Open-Angle Glaucoma market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Open-Angle Glaucoma Pipeline Development Activities

The Open-Angle Glaucoma report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Open-Angle Glaucoma key players involved in developing targeted therapeutics.

Request for a sample report to understand more about the Open-Angle Glaucoma pipeline development activities at: https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Therapeutics Assessment

Key pharma players such as Aerie Pharmaceuticals, Alcon Research, Allergan, Bausch and Lomb, Chong Kun Dang Pharmaceutical, D.Western Therapeutics Institute (DWTI)/Kowa LTD., Envisia Therapeutics, Laboratorios Sophia S.A de C.V., Merck Sharp & Dohme Corp., Nicox Ophthalmics, Novartis, Alcon Research, Ocuphire Pharma, Ono Pharmaceutical, Peregrine Ophthalmic, Perrigo Company, Santen Inc., Santen Pharmaceutical, Sun Pharma Advanced Research Company Limited (SPARC), Sylentis, Ube Industries, and others are working proactively in the Open-Angle Glaucoma Therapeutics market to develop novel therapies which will drive the Open-Angle Glaucoma treatment markets in the upcoming years.

Learn more about the emerging therapies & key companies at: https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Report Key Insights

1. Open-Angle Glaucoma Patient Population
2. Open-Angle Glaucoma Market Size and Trends
3. Key Cross Competition in the Open-Angle Glaucoma Market
4. Open-Angle Glaucoma Market Dynamics (Key Drivers and Barriers)
5. Open-Angle Glaucoma Market Opportunities
6. Open-Angle Glaucoma Therapeutic Approaches
7. Open-Angle Glaucoma Pipeline Analysis
8. Open-Angle Glaucoma Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Open-Angle Glaucoma Market

Table of Contents

1. Key Insights
2. Executive Summary
3. Open-Angle Glaucoma Competitive Intelligence Analysis
4. Open-Angle Glaucoma Market Overview at a Glance
5. Open-Angle Glaucoma Disease Background and Overview
6. Open-Angle Glaucoma Patient Journey
7. Open-Angle Glaucoma Epidemiology and Patient Population
8. Open-Angle Glaucoma Treatment Algorithm, Current Treatment, and Medical Practices
9. Open-Angle Glaucoma Unmet Needs
10. Key Endpoints of Open-Angle Glaucoma Treatment
11. Open-Angle Glaucoma Marketed Products
12. Open-Angle Glaucoma Emerging Therapies
13. Open-Angle Glaucoma Seven Major Market Analysis
14. Attribute Analysis
15. Open-Angle Glaucoma Market Outlook (7 major markets)
16. Open-Angle Glaucoma Access and Reimbursement Overview
17. KOL Views on the Open-Angle Glaucoma Market
18. Open-Angle Glaucoma Market Drivers
19. Open-Angle Glaucoma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Open-Angle Glaucoma Market report here: https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Us:

Kritika Rehani
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.